175 related articles for article (PubMed ID: 10455212)
1. Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine-needle aspiration cytology.
Abati A; Sanjuan X; Wilder A; Linehan WM; Hewitt SM; Merino MJ
Cancer; 1999 Aug; 87(4):231-7. PubMed ID: 10455212
[TBL] [Abstract][Full Text] [Related]
2. Fine-needle aspiration of metastatic clear cell carcinoma of the kidney: employment of microdissection and the polymerase chain reaction as a potential diagnostic tool.
Beaty MW; Zhuang Z; Park WS; Emmert-Buck MR; Linehan WM; Lubensky IA; Abati A
Cancer; 1997 Jun; 81(3):180-6. PubMed ID: 9196017
[TBL] [Abstract][Full Text] [Related]
3. Utilization of molecular genetics in the differentiation between adrenal cortical adenomas and carcinomas.
Fogt F; Vargas MP; Zhuang Z; Merino MJ
Hum Pathol; 1998 May; 29(5):518-21. PubMed ID: 9596277
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic ultrasound-guided fine-needle aspiration biopsy of the adrenal glands: analysis of 24 patients.
Jhala NC; Jhala D; Eloubeidi MA; Chhieng DC; Crowe DR; Roberson J; Eltoum I
Cancer; 2004 Oct; 102(5):308-14. PubMed ID: 15376200
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity at chromosome segment Xq25-26.1 in advanced human ovarian carcinomas.
Choi C; Cho S; Horikawa I; Berchuck A; Wang N; Cedrone E; Jhung SW; Lee JB; Kerr J; Chenevix-Trench G; Kim S; Barrett JC; Koi M
Genes Chromosomes Cancer; 1997 Nov; 20(3):234-42. PubMed ID: 9365830
[TBL] [Abstract][Full Text] [Related]
6. Morphologic diversity in malignant melanoma: the potential use of microdissection and the polymerase chain reaction for diagnosis.
Quezado MM; Abati AD; Albuquerque AV; Wilson J; Merino MJ; Filie AC
Mod Pathol; 1998 Oct; 11(10):1010-5. PubMed ID: 9796732
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract][Full Text] [Related]
9. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity: comparison between fine-needle aspiration and biopsy specimens for the detection of tumor cells.
Naritoku WY; Datar RH; Li P; Groshen SL; Taylor CR; Imam SA
Cancer; 1999 Aug; 87(4):210-5. PubMed ID: 10455209
[TBL] [Abstract][Full Text] [Related]
11. Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues.
Simsir A; Palacios D; Linehan WM; Merino MJ; Abati A
Diagn Cytopathol; 2001 May; 24(5):328-32. PubMed ID: 11335962
[TBL] [Abstract][Full Text] [Related]
12. Clonal origin of lymph node metastases in bladder carcinoma.
Jones TD; Carr MD; Eble JN; Wang M; Lopez-Beltran A; Cheng L
Cancer; 2005 Nov; 104(9):1901-10. PubMed ID: 16196038
[TBL] [Abstract][Full Text] [Related]
13. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
[TBL] [Abstract][Full Text] [Related]
14. The Tall cell variant of papillary carcinoma of the thyroid: cytologic features and loss of heterozygosity of metastatic and/or recurrent neoplasms and primary neoplasms.
Filie AC; Chiesa A; Bryant BR; Merino MJ; Sobel ME; Abati A
Cancer; 1999 Aug; 87(4):238-42. PubMed ID: 10455213
[TBL] [Abstract][Full Text] [Related]
15. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas.
Vortmeyer AO; Lubensky IA; Fogt F; Linehan WM; Khettry U; Zhuang Z
Am J Pathol; 1997 Oct; 151(4):951-6. PubMed ID: 9327728
[TBL] [Abstract][Full Text] [Related]
16. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
17. Myoepithelial cell-rich neoplasms: cytologic features of benign and malignant lesions.
Darvishian F; Lin O
Cancer; 2004 Dec; 102(6):355-61. PubMed ID: 15476290
[TBL] [Abstract][Full Text] [Related]
18. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
19. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
20. Genetic heterogeneity of surgically resected prostate carcinomas and their biopsy specimens is related to their histologic differentiation.
Takimoto Y; Shimazui T; Akaza H; Sato N; Noguchi M
Cancer; 2001 Jan; 91(2):362-70. PubMed ID: 11180083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
